Literature DB >> 33821916

Celecoxib for Stage III Colon Cancer.

David J Kerr1, Sarah Chamberlain2, Rachel S Kerr3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33821916     DOI： 10.1001/jama.2021.2651

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats.

Authors:  Guoying Zhu; Li Chen; Su Liu; Ling She; Yongnian Ding; Changqing Yang; Fengshang Zhu
Journal:  Heliyon       Date:  2022-07-05

2.  In Silico Approach Using Free Software to Optimize the Antiproliferative Activity and Predict the Potential Mechanism of Action of Pyrrolizine-Based Schiff Bases.

Authors:  Faisal A Almalki; Ashraf N Abdalla; Ahmed M Shawky; Mahmoud A El Hassab; Ahmed M Gouda
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.